{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:52:27Z","timestamp":1791924747391,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Improved cancer treatment outcomes have increased the demand for medical care that considers the quality of life of patients with cancer. Patient-reported outcomes (PROs) help assess the quality of life because they involve direct evaluation of the patients. Recently, electronic PROs (ePROs) have been used in clinical cancer care settings in Europe and the United States. Electronic PROs positively affected communication between patients with cancer and healthcare providers, enhanced education, optimized self-management, contributed to healthcare economics, assisted in monitoring adverse events, and improved prognosis. However, challenges such as adherence, burden on healthcare providers, lack of personalized formats, low digital literacy, and implementation costs remain. Therefore, carefully selecting the items to be recorded by ePROs in alignment with specific objectives is essential. Additionally, developing systems using lifelogs\u2014digital records of daily activities\u2014and creating mechanisms that automatically encourage patient behavioral changes based on the reported data are crucial. This review delineates the advantages and challenges of ePROs according to their history and proposes the prospects of ePRO.<\/jats:p>","DOI":"10.1007\/s10147-024-02651-8","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T04:05:35Z","timestamp":1731729935000},"page":"1-16","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Electronic patient-reported outcomes as digital therapeutics for patients with cancer: a narrative review of current practices and future directions"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7669-1405","authenticated-orcid":false,"given":"Ken","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Higashiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Umemiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Inayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayami","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rin","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Taki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yamanoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzo","family":"Hamanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Mandai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"issue":"12","key":"2651_CR1","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1007\/s10147-022-02244-3","volume":"27","author":"KKY Leung","year":"2022","unstructured":"Leung KKY, Ray S, Chan GCF et al (2022) Functional outcomes at PICU discharge in hemato-oncology children at a tertiary oncology center in Hong Kong. Int J Clin Oncol 27(12):1904\u20131915. https:\/\/doi.org\/10.1007\/s10147-022-02244-3","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"2651_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/annonc\/mdx757","volume":"29","author":"K Jordan","year":"2018","unstructured":"Jordan K, Aapro M, Kaasa S et al (2018) European society for medical oncology (ESMO) position paper on supportive and palliative care. Ann Oncol 29(1):36\u201343. https:\/\/doi.org\/10.1093\/annonc\/mdx757","journal-title":"Ann Oncol"},{"issue":"11","key":"2651_CR3","doi-asserted-by":"publisher","first-page":"e588","DOI":"10.1016\/S1470-2045(18)30415-7","volume":"19","author":"S Kaasa","year":"2018","unstructured":"Kaasa S, Loge JH, Aapro M et al (2018) Integration of oncology and palliative care: a lancet oncology commission. Lancet Oncol 19(11):e588\u2013e653. https:\/\/doi.org\/10.1016\/S1470-2045(18)30415-7","journal-title":"Lancet Oncol"},{"issue":"1","key":"2651_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4828\/aro.2022.39","volume":"2","author":"G Gussoni","year":"2022","unstructured":"Gussoni G, Ravot E, Zecchina M et al (2022) Digital therapeutics in oncology: findings, barriers and prospects. A narrative review. Ann Res Oncol 2(1):55\u201369. https:\/\/doi.org\/10.4828\/aro.2022.39","journal-title":"Ann Res Oncol"},{"issue":"3","key":"2651_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10147-022-02289-4","volume":"28","author":"Y Inayama","year":"2023","unstructured":"Inayama Y, Mizuno K, Yamaguchi K et al (2023) Real-world practice of estrogen therapy after surgery for endometrial cancer: a descriptive study using a Japanese claims database. Int J Clin Oncol 28(3):445\u2013453. https:\/\/doi.org\/10.1007\/s10147-022-02289-4","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"2651_CR6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s10147-017-1117-y","volume":"22","author":"H Sasaki","year":"2017","unstructured":"Sasaki H, Tamura K, Naito Y et al (2017) Patient perceptions of symptoms and concerns during cancer chemotherapy: 'affects my family\u2019 is the most important. Int J Clin Oncol 22(4):793\u2013800. https:\/\/doi.org\/10.1007\/s10147-017-1117-y","journal-title":"Int J Clin Oncol"},{"issue":"23","key":"2651_CR7","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/jnci\/djp386","volume":"101","author":"E Basch","year":"2009","unstructured":"Basch E, Jia X, Heller G et al (2009) Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst 101(23):1624\u20131632. https:\/\/doi.org\/10.1093\/jnci\/djp386","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"2651_CR8","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1056\/NEJMp0911494","volume":"362","author":"E Basch","year":"2010","unstructured":"Basch E (2010) The missing voice of patients in drug-safety reporting. N Engl J Med 362(10):865\u2013869. https:\/\/doi.org\/10.1056\/NEJMp0911494","journal-title":"N Engl J Med"},{"issue":"9","key":"2651_CR9","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.2196\/jmir.6414","volume":"18","author":"M Egbring","year":"2016","unstructured":"Egbring M, Far E, Roos M et al (2016) A mobile app to stabilize daily functional activity of breast cancer patients in collaboration with the physician: a randomized controlled clinical trial. J Med Internet Res 18(9):e238. https:\/\/doi.org\/10.2196\/jmir.6414","journal-title":"J Med Internet Res"},{"issue":"3","key":"2651_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.clbc.2020.01.004","volume":"20","author":"S Handa","year":"2020","unstructured":"Handa S, Okuyama H, Yamamoto H et al (2020) Effectiveness of a smartphone application as a support tool for patients undergoing breast cancer chemotherapy: a randomized controlled trial. Clin Breast Cancer 20(3):201\u2013208. https:\/\/doi.org\/10.1016\/j.clbc.2020.01.004","journal-title":"Clin Breast Cancer"},{"key":"2651_CR11","unstructured":"Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. (2009). https:\/\/www.fda.gov\/media\/77832\/download. Accessed on 30 July 2024"},{"issue":"5","key":"2651_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrclinonc.2015.222","volume":"13","author":"M Di Maio","year":"2016","unstructured":"Di Maio M, Basch E, Bryce J et al (2016) Patient-reported outcomes in the evaluation of toxicity of anticancer treatments. Nat Rev Clin Oncol 13(5):319\u2013325. https:\/\/doi.org\/10.1038\/nrclinonc.2015.222","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"2651_CR13","doi-asserted-by":"publisher","first-page":"151473","DOI":"10.1016\/j.soncn.2023.151473","volume":"39","author":"T Wang","year":"2023","unstructured":"Wang T, Ho MH, Tong MCF et al (2023) Effects of patient-reported outcome tracking and health information provision via remote patient monitoring software on patient outcomes in oncology care: a systematic review and meta-analysis. Semin Oncol Nurs 39(5):151473. https:\/\/doi.org\/10.1016\/j.soncn.2023.151473","journal-title":"Semin Oncol Nurs"},{"key":"2651_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cct.2015.04.004","volume":"43","author":"E Vodicka","year":"2015","unstructured":"Vodicka E, Kim K, Devine EB et al (2015) Inclusion of patient-reported outcome measures in registered clinical trials: evidence from ClinicalTrials.gov (2007\u20132013). Contemp Clin Trials 43:1\u20139. https:\/\/doi.org\/10.1016\/j.cct.2015.04.004","journal-title":"Contemp Clin Trials"},{"key":"2651_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/1472-6963-13-211","volume":"13","author":"J Chen","year":"2013","unstructured":"Chen J, Ou L, Hollis SJ (2013) A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res 13:211. https:\/\/doi.org\/10.1186\/1472-6963-13-211","journal-title":"BMC Health Serv Res"},{"issue":"14","key":"2651_CR16","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.2013.53.5948","volume":"32","author":"G Kotronoulas","year":"2014","unstructured":"Kotronoulas G, Kearney N, Maguire R et al (2014) What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol 32(14):1480\u20131501. https:\/\/doi.org\/10.1200\/JCO.2013.53.5948","journal-title":"J Clin Oncol"},{"issue":"9","key":"2651_CR17","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/annonc\/mdv181","volume":"26","author":"D Howell","year":"2015","unstructured":"Howell D, Molloy S, Wilkinson K et al (2015) Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Ann Oncol 26(9):1846\u20131858. https:\/\/doi.org\/10.1093\/annonc\/mdv181","journal-title":"Ann Oncol"},{"issue":"3","key":"2651_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1200\/JCO.2013.48.6662","volume":"32","author":"DL Berry","year":"2014","unstructured":"Berry DL, Hong F, Halpenny B et al (2014) Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial. J Clin Oncol 32(3):199\u2013205. https:\/\/doi.org\/10.1200\/JCO.2013.48.6662","journal-title":"J Clin Oncol"},{"issue":"2","key":"2651_CR19","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/annonc\/mdv576","volume":"27","author":"F Strasser","year":"2016","unstructured":"Strasser F, Blum D, von Moos R et al (2016) The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95\/06). Ann Oncol 27(2):324\u2013332. https:\/\/doi.org\/10.1093\/annonc\/mdv576","journal-title":"Ann Oncol"},{"issue":"6","key":"2651_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E, Deal AM, Kris MG et al (2016) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 34(6):557\u2013565. https:\/\/doi.org\/10.1200\/JCO.2015.63.0830","journal-title":"J Clin Oncol"},{"key":"2651_CR21","doi-asserted-by":"publisher","first-page":"e38333","DOI":"10.2196\/38333","volume":"25","author":"K Lee","year":"2023","unstructured":"Lee K, Kim S, Kim SH et al (2023) Digital health interventions for adult patients with cancer evaluated in randomized controlled trials: scoping review. J Med Internet Res 25:e38333. https:\/\/doi.org\/10.2196\/38333","journal-title":"J Med Internet Res"},{"issue":"8","key":"2651_CR22","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1200\/JCO.2010.29.8315","volume":"29","author":"CS Cleeland","year":"2011","unstructured":"Cleeland CS, Wang XS, Shi Q et al (2011) Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol 29(8):994\u20131000. https:\/\/doi.org\/10.1200\/JCO.2010.29.8315","journal-title":"J Clin Oncol"},{"issue":"2","key":"2651_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jama.2017.7156","volume":"318","author":"E Basch","year":"2017","unstructured":"Basch E, Deal AM, Dueck AC et al (2017) Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA 318(2):197\u2013198. https:\/\/doi.org\/10.1001\/jama.2017.7156","journal-title":"JAMA"},{"key":"2651_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx029","author":"F Denis","year":"2017","unstructured":"Denis F, Lethrosne C, Pourel N et al (2017) Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djx029","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"2651_CR25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10147-024-02493-4","volume":"29","author":"T Hashimoto","year":"2024","unstructured":"Hashimoto T, Nakamura Y, Oki E et al (2024) Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assay. Int J Clin Oncol 29(5):495\u2013511. https:\/\/doi.org\/10.1007\/s10147-024-02493-4","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"2651_CR26","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1016\/S2589-7500(22)00249-7","volume":"5","author":"FJ Pearce","year":"2023","unstructured":"Pearce FJ, Cruz Rivera S, Liu X et al (2023) The role of patient-reported outcome measures in trials of artificial intelligence health technologies: a systematic evaluation of ClinicalTrials.gov records (1997\u20132022). Lancet Digit Health 5(3):e160\u2013e167. https:\/\/doi.org\/10.1016\/S2589-7500(22)00249-7","journal-title":"Lancet Digit Health"},{"issue":"6","key":"2651_CR27","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S1470-2045(23)00157-2","volume":"24","author":"M Pe","year":"2023","unstructured":"Pe M, Alanya A, Falk RS et al (2023) Setting international standards in analyzing patient-reported outcomes and quality of life endpoints in cancer clinical trials-innovative medicines initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures. Lancet Oncol 24(6):e270\u2013e283. https:\/\/doi.org\/10.1016\/S1470-2045(23)00157-2","journal-title":"Lancet Oncol"},{"issue":"15","key":"2651_CR28","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1021\/acs.jpcb.0c00490","volume":"124","author":"A Yang","year":"2020","unstructured":"Yang A, Moore TC, Iacovella CR et al (2020) Examining tail and headgroup effects on binary and ternary gel-phase lipid bilayer structure. J Phys Chem B 124(15):3043\u20133053. https:\/\/doi.org\/10.1021\/acs.jpcb.0c00490","journal-title":"J Phys Chem B"},{"issue":"1","key":"2651_CR29","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1186\/s12913-023-10426-6","volume":"23","author":"H Knowles","year":"2023","unstructured":"Knowles H, Swoboda TK, Sandlin D et al (2023) The association between electronic health information usage and patient-centered communication: a cross sectional analysis from the health information national trends survey (HINTS). BMC Health Serv Res 23(1):1398. https:\/\/doi.org\/10.1186\/s12913-023-10426-6","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"2651_CR30","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1200\/JCO.2010.30.3909","volume":"29","author":"DL Berry","year":"2011","unstructured":"Berry DL, Blumenstein BA, Halpenny B et al (2011) Enhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial. J Clin Oncol 29(8):1029\u20131035. https:\/\/doi.org\/10.1200\/JCO.2010.30.3909","journal-title":"J Clin Oncol"},{"key":"2651_CR31","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1200\/CCI.20.00081","volume":"4","author":"E Basch","year":"2020","unstructured":"Basch E, Stover AM, Schrag D et al (2020) Clinical Utility and user perceptions of a digital system for electronic patient-reported symptom monitoring during routine cancer care: findings from the PRO-TECT Trial. JCO Clin Cancer Inform 4:947\u2013957. https:\/\/doi.org\/10.1200\/CCI.20.00081","journal-title":"JCO Clin Cancer Inform"},{"issue":"1","key":"2651_CR32","doi-asserted-by":"publisher","first-page":"e000130","DOI":"10.1136\/bmjsit-2021-000130","volume":"4","author":"A Gvozdanovic","year":"2022","unstructured":"Gvozdanovic A, Jozsa F, Fersht N et al (2022) Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1). BMJ Surg Interv Health Technol 4(1):e000130. https:\/\/doi.org\/10.1136\/bmjsit-2021-000130","journal-title":"BMJ Surg Interv Health Technol"},{"issue":"1","key":"2651_CR33","doi-asserted-by":"publisher","first-page":"e15588","DOI":"10.2196\/15588","volume":"3","author":"J Meirte","year":"2020","unstructured":"Meirte J, Hellemans N, Anthonissen M et al (2020) Benefits and disadvantages of electronic patient-reported outcome measures: systematic review. JMIR Perioper Med 3(1):e15588. https:\/\/doi.org\/10.2196\/15588","journal-title":"JMIR Perioper Med"},{"issue":"12","key":"2651_CR34","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1007\/s10147-020-01765-z","volume":"25","author":"K Kawaguchi","year":"2020","unstructured":"Kawaguchi K, Kawazoe H, Sakurai T et al (2020) Effect of general self-efficacy on promoting health-related quality of life during recovery from radical prostatectomy: a 1-year prospective study. Int J Clin Oncol 25(12):2122\u20132129. https:\/\/doi.org\/10.1007\/s10147-020-01765-z","journal-title":"Int J Clin Oncol"},{"issue":"9","key":"2651_CR35","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1093\/annonc\/mdx317","volume":"28","author":"P Holch","year":"2017","unstructured":"Holch P, Warrington L, Bamforth LCA et al (2017) Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment. Ann Oncol 28(9):2305\u20132311. https:\/\/doi.org\/10.1093\/annonc\/mdx317","journal-title":"Ann Oncol"},{"issue":"7","key":"2651_CR36","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1200\/JCO.20.02015","volume":"39","author":"K Absolom","year":"2021","unstructured":"Absolom K, Warrington L, Hudson E et al (2021) Phase III randomized controlled trial of eRAPID: eHealth Intervention during chemotherapy. J Clin Oncol 39(7):734\u2013747. https:\/\/doi.org\/10.1200\/JCO.20.02015","journal-title":"J Clin Oncol"},{"issue":"4","key":"2651_CR37","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.2196\/medinform.5359","volume":"4","author":"CS Kruse","year":"2016","unstructured":"Kruse CS, Goswamy R, Raval Y et al (2016) Challenges and opportunities of big data in health care: a systematic review. JMIR Med Inform 4(4):e38. https:\/\/doi.org\/10.2196\/medinform.5359","journal-title":"JMIR Med Inform"},{"issue":"10","key":"2651_CR38","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1007\/s00520-020-05539-1","volume":"28","author":"M Aapro","year":"2020","unstructured":"Aapro M, Bossi P, Dasari A et al (2020) Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives. Support Care Cancer 28(10):4589\u20134612. https:\/\/doi.org\/10.1007\/s00520-020-05539-1","journal-title":"Support Care Cancer"},{"issue":"21","key":"2651_CR39","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1200\/JCO.2017.76.3839","volume":"36","author":"LB Kenney","year":"2018","unstructured":"Kenney LB, Antal Z, Ginsberg JP et al (2018) Improving male reproductive health after childhood, adolescent, and young adult cancer: progress and future directions for survivorship research. J Clin Oncol 36(21):2160\u20132168. https:\/\/doi.org\/10.1200\/JCO.2017.76.3839","journal-title":"J Clin Oncol"},{"issue":"5","key":"2651_CR40","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s00520-017-3970-7","volume":"26","author":"NA Kolb","year":"2018","unstructured":"Kolb NA, Smith AG, Singleton JR et al (2018) Chemotherapy-related neuropathic symptom management: a randomized trial of an automated symptom-monitoring system paired with nurse practitioner follow-up. Support Care Cancer 26(5):1607\u20131615. https:\/\/doi.org\/10.1007\/s00520-017-3970-7","journal-title":"Support Care Cancer"},{"issue":"6","key":"2651_CR41","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.2196\/jmir.4190","volume":"17","author":"DL Berry","year":"2015","unstructured":"Berry DL, Blonquist TM, Patel RA et al (2015) Exposure to a patient-centered, Web-based intervention for managing cancer symptom and quality of life issues: impact on symptom distress. J Med Internet Res 17(6):e136. https:\/\/doi.org\/10.2196\/jmir.4190","journal-title":"J Med Internet Res"},{"issue":"1","key":"2651_CR42","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s12913-020-05293-4","volume":"20","author":"M Ferrua","year":"2020","unstructured":"Ferrua M, Minvielle E, Fourcade A et al (2020) How to design a remote patient monitoring system? A French case study. BMC Health Serv Res 20(1):434. https:\/\/doi.org\/10.1186\/s12913-020-05293-4","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"2651_CR43","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/s41591-022-01788-1","volume":"28","author":"O Mir","year":"2022","unstructured":"Mir O, Ferrua M, Fourcade A et al (2022) Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial. Nat Med 28(6):1224\u20131231. https:\/\/doi.org\/10.1038\/s41591-022-01788-1","journal-title":"Nat Med"},{"issue":"24","key":"2651_CR44","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1001\/jama.2022.9265","volume":"327","author":"E Basch","year":"2022","unstructured":"Basch E, Schrag D, Henson S et al (2022) Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial. JAMA 327(24):2413\u20132422. https:\/\/doi.org\/10.1001\/jama.2022.9265","journal-title":"JAMA"},{"issue":"8","key":"2651_CR45","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.annonc.2023.05.003","volume":"34","author":"N Harbeck","year":"2023","unstructured":"Harbeck N, Fasching PA, Wuerstlein R et al (2023) Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial. Ann Oncol 34(8):660\u2013669. https:\/\/doi.org\/10.1016\/j.annonc.2023.05.003","journal-title":"Ann Oncol"},{"key":"2651_CR46","doi-asserted-by":"publisher","first-page":"e51949","DOI":"10.2196\/51949","volume":"26","author":"F Springer","year":"2024","unstructured":"Springer F, Maier A, Friedrich M et al (2024) Digital therapeutic (Mika) targeting distress in patients with cancer: results from a nationwide waitlist randomized controlled trial. J Med Internet Res 26:e51949. https:\/\/doi.org\/10.2196\/51949","journal-title":"J Med Internet Res"},{"issue":"2","key":"2651_CR47","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/S2589-7500(19)30027-5","volume":"1","author":"A Ferretti","year":"2019","unstructured":"Ferretti A, Ronchi E, Vayena E (2019) From principles to practice: benchmarking government guidance on health apps. Lancet Digit Health 1(2):e55\u2013e57. https:\/\/doi.org\/10.1016\/S2589-7500(19)30027-5","journal-title":"Lancet Digit Health"},{"issue":"1","key":"2651_CR48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00520-013-1954-9","volume":"22","author":"F Denis","year":"2014","unstructured":"Denis F, Viger L, Charron A et al (2014) Detecting lung cancer relapse using self-evaluation forms weekly filled at home: the sentinel follow-up. Support Care Cancer 22(1):79\u201385. https:\/\/doi.org\/10.1007\/s00520-013-1954-9","journal-title":"Support Care Cancer"},{"issue":"6","key":"2651_CR49","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s00520-013-2111-1","volume":"22","author":"F Denis","year":"2014","unstructured":"Denis F, Viger L, Charron A et al (2014) Detection of lung cancer relapse using self-reported symptoms transmitted via an internet web-application: pilot study of the sentinel follow-up. Support Care Cancer 22(6):1467\u20131473. https:\/\/doi.org\/10.1007\/s00520-013-2111-1","journal-title":"Support Care Cancer"},{"issue":"3","key":"2651_CR50","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1001\/jama.2018.18085","volume":"321","author":"F Denis","year":"2019","unstructured":"Denis F, Basch E, Septans AL et al (2019) Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer. JAMA 321(3):306\u2013307. https:\/\/doi.org\/10.1001\/jama.2018.18085","journal-title":"JAMA"},{"issue":"4","key":"2651_CR51","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.semradonc.2023.07.002","volume":"33","author":"LR Narra","year":"2023","unstructured":"Narra LR, Verdini N, Lapen K et al (2023) Patient-reported outcomes in clinical trials: from an endpoint to an intervention in cancer care. Semin Radiat Oncol 33(4):358\u2013366. https:\/\/doi.org\/10.1016\/j.semradonc.2023.07.002","journal-title":"Semin Radiat Oncol"},{"issue":"7","key":"2651_CR52","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s11136-024-03675-3","volume":"33","author":"GL Mazza","year":"2024","unstructured":"Mazza GL, Dueck AC, Ginos B et al (2024) Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39). Qual Life Res 33(7):1985\u20131995. https:\/\/doi.org\/10.1007\/s11136-024-03675-3","journal-title":"Qual Life Res"},{"key":"2651_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s10389-022-01767-3","author":"TR Kiderlen","year":"2022","unstructured":"Kiderlen TR, Schnack A, de Wit M (2022) Essential barriers and considerations for the implementation of electronic patient-reported outcome (ePRO) measures in oncological practice: contextualizing the results of a feasibility study with existing literature. J Public Health. https:\/\/doi.org\/10.1007\/s10389-022-01767-3","journal-title":"J Public Health"},{"key":"2651_CR54","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju244","author":"E Basch","year":"2014","unstructured":"Basch E, Reeve BB, Mitchell SA et al (2014) Development of the national cancer institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/dju244","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2651_CR55","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1740774517698645","volume":"14","author":"TR Mendoza","year":"2017","unstructured":"Mendoza TR, Dueck AC, Bennett AV et al (2017) Evaluation of different recall periods for the US national cancer institute\u2019s PRO-CTCAE. Clin Trials 14(3):255\u2013263. https:\/\/doi.org\/10.1177\/1740774517698645","journal-title":"Clin Trials"},{"issue":"4","key":"2651_CR56","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1200\/JCO.2004.06.078","volume":"22","author":"G Velikova","year":"2004","unstructured":"Velikova G, Booth L, Smith AB et al (2004) Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol 22(4):714\u2013724. https:\/\/doi.org\/10.1200\/JCO.2004.06.078","journal-title":"J Clin Oncol"},{"key":"2651_CR57","doi-asserted-by":"publisher","unstructured":"Recommended dietary allowances for the elderly (1986). N Engl J Med 314 (26):1707\u20131710. https:\/\/doi.org\/10.1056\/NEJM198606263142612","DOI":"10.1056\/NEJM198606263142612"},{"issue":"9","key":"2651_CR58","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.annonc.2022.04.007","volume":"33","author":"M Di Maio","year":"2022","unstructured":"Di Maio M, Basch E, Denis F et al (2022) The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO clinical practice guideline. Ann Oncol 33(9):878\u2013892. https:\/\/doi.org\/10.1016\/j.annonc.2022.04.007","journal-title":"Ann Oncol"},{"issue":"1","key":"2651_CR59","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1470-2045(19)30675-8","volume":"21","author":"A van der Hout","year":"2020","unstructured":"van der Hout A, van Uden-Kraan CF, Holtmaat K et al (2020) Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomized, controlled trial. Lancet Oncol 21(1):80\u201394. https:\/\/doi.org\/10.1016\/S1470-2045(19)30675-8","journal-title":"Lancet Oncol"},{"issue":"4","key":"2651_CR60","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/0284186X.2020.1851764","volume":"60","author":"A van der Hout","year":"2021","unstructured":"van der Hout A, Holtmaat K, Jansen F et al (2021) The eHealth self-management application \u2018Oncokompas\u2019 that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most? Acta Oncol 60(4):403\u2013411. https:\/\/doi.org\/10.1080\/0284186X.2020.1851764","journal-title":"Acta Oncol"},{"key":"2651_CR61","doi-asserted-by":"publisher","first-page":"e2300162","DOI":"10.1200\/CCI.23.00162","volume":"8","author":"LA Shipman","year":"2024","unstructured":"Shipman LA, Price J, Abdulwahid D et al (2024) Service evaluation of MyChristie-MyHealth, an electronic patient-reported outcome measure integrated into clinical cancer care. JCO Clin Cancer Inform 8:e2300162. https:\/\/doi.org\/10.1200\/CCI.23.00162","journal-title":"JCO Clin Cancer Inform"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-024-02651-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-024-02651-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-024-02651-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T18:02:42Z","timestamp":1736013762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-024-02651-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["2651"],"URL":"https:\/\/doi.org\/10.1007\/s10147-024-02651-8","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"7 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"K. Yamaguchi reports personal fees and other support from DUMSCO Inc. and personal fees from Takeda Pharmaceutical Company Limited, Eisai Co., Ltd., Daiichi Sankyo, Inc., and Merck & Co., Inc. outside the submitted work. M. Mandai reports support from DUMSCO, Inc. outside the submitted work. N Higashiyama reports personal fees from DUMSCO Inc. outside the submitted work. No competing interests have been reported by the other authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}